Clinical Trial Update: VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study of first-line therapy for non-transplant-eligible multiple myeloma patients using VTD followed by MPT main…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Melphalan (Melphalan)
• PREDNISONE (Prednisone)
• Thalomid (thalidomide)
• Velcade (bortezomib)

Snippet

Sponsor: Korean Multiple Myeloma Working Party | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED